Hi Guest Login
Upload Prescription
Home > Oncotype Dx Dcis Test > Noida > Sector 55
The Oncotype DX DCIS Test in Sector 55, Noida, provided by MAX@Home, is an advanced genomic test for patients with Ductal Carcinoma In Situ (DCIS). It assesses the risk of cancer recurrence and supports personalised treatment decisions, particularly regarding radiation therapy after surgery.
By analysing the tumor’s genetic profile, the test offers insights beyond standard pathology, enabling doctors to recommend the most appropriate, individualised treatment plan. MAX@Home provides seamless coordination and expert support for a reliable testing experience.
The Oncotype DX DCIS Test is a genomic assay that evaluates the activity of specific genes in tumor tissue obtained during breast surgery. It generates a DCIS Score, which predicts the likelihood of cancer returning in the same breast.
Unlike traditional reports, this test provides deeper insights into tumor behavior, helping oncologists determine whether additional treatments like radiation therapy are necessary after surgery.
This test plays a key role in personalised breast cancer care by enabling more informed decisions:
Analyses the activity of specific genes within the tumor to better understand how aggressive the DCIS is and how it is likely to behave over time. This provides deeper information beyond standard pathology reports.
Generates a DCIS Score that predicts the likelihood of cancer returning in the same breast or progressing to invasive cancer, helping patients and doctors better understand future risk.
Helps identify which patients are more likely to benefit from radiation therapy after surgery and those who may safely avoid it, reducing unnecessary exposure to treatment.
Combines genomic insights with clinical and pathology factors to create a treatment plan tailored specifically to the patient’s condition and risk profile.
Minimises the chances of undergoing unnecessary therapies and their potential side effects, ensuring treatment is aligned with the actual level of risk.
The Oncotype DX DCIS Test is particularly valuable for patients facing complex post-surgery treatment decisions, especially about radiation therapy. It offers deeper insights into tumor biology, supporting more confident, personalised decisions for both patients and doctors.
This test is designed for individuals diagnosed with DCIS, a non-invasive form of breast cancer. It is particularly helpful in understanding the risk of recurrence after initial treatment.
The test uses tumor tissue already removed during surgery, such as a lumpectomy. It is most relevant after surgery, when decisions about further treatment are required.
For many patients, the benefit of radiation therapy in reducing recurrence risk is uncertain. This test helps identify who is more likely to benefit from radiation and who may safely avoid it.
Patients seeking a tailored approach can benefit from this genomic test, which provides insights based on the unique genetic profile of their tumor, beyond standard clinical factors.
If your oncologist recommends genomic testing for your treatment planning, the Oncotype DX DCIS Test is a clinically validated option widely used in breast cancer care.
Important Note:
Not all DCIS patients require this test. Always consult your oncologist to determine suitability.
Your oncologist reviews your diagnosis, pathology reports, and overall health to determine if the Oncotype DX DCIS Test is appropriate. This ensures the test is clinically relevant and supports your treatment decisions.
The tumor tissue previously removed during surgery (such as a lumpectomy) is identified and retrieved from the hospital or pathology laboratory where it is stored. No additional procedure or sample collection is required.
MAX@Home manages all coordination, including documentation, sample collection, packaging, and secure transport to a certified genomic laboratory. Strict protocols are followed to maintain sample integrity.
At the laboratory, advanced genomic testing analyses the activity of specific genes within the tumor. A detailed report is then generated, including the DCIS Score, which indicates the risk of recurrence.
Once the report is ready, your oncologist explains the results and discusses their implications for your treatment. These findings, combined with clinical factors, guide decisions about additional treatments such as radiation therapy.
|
DCIS Score |
Risk Level |
What It Indicates |
|
Low Score |
Low Risk |
Indicates a lower chance of cancer recurrence; radiation therapy may not be necessary. |
|
Intermediate Score |
Moderate Risk |
Suggests a moderate risk of recurrence; treatment decisions depend on clinical evaluation and doctor’s advice. |
|
High Score |
High Risk |
Indicates a higher likelihood of recurrence; radiation therapy is generally recommended. |
Note: Final decisions should always be made in consultation with your oncologist.
Choosing the Oncotype DX DCIS Test in Sector 55, Noida with MAX@Home provides advanced genomic insights and a patient-focused experience. Expert clinical guidance and seamless coordination are designed to reduce stress and support confident, informed treatment decisions.
Experienced healthcare professionals and oncologists guide the process, ensuring the test is recommended appropriately and performed with precision for accurate, reliable results.
Experience complete coordination, from tumor sample retrieval and documentation to lab processing and report delivery, without the need for multiple hospital visits.
Your tissue samples are handled and transported according to strict medical protocols to maintain integrity. Patient data is protected with high standards of privacy and confidentiality.
You will receive clear communication on timelines, documentation, and pricing at every step, ensuring a smooth experience with no hidden steps or unexpected costs.
Selecting the right healthcare partner for genomic testing is essential, as it affects the accuracy, coordination, and overall experience of your cancer care. With MAX@Home, each step from test recommendation to report delivery is managed with clinical expertise, precision, and a focus on patient comfort.
Supported by a strong clinical network and experienced oncology specialists, MAX@Home ensures reliable testing and accurate guidance at every step.
We manage the entire process, including hospital coordination, sample retrieval, lab processing, logistics, and documentation, to ensure a hassle-free experience.
Efficient coordination and streamlined processes ensure results are delivered within the expected timeline, enabling timely and confident treatment decisions.
Our dedicated care team supports you throughout the process, from explaining the test to guiding you through reports and next steps with clarity and care.
We work closely with your oncologist to ensure test results are integrated into your overall treatment strategy for better, personalised outcomes.
Gain clarity on your recurrence risk and make confident treatment decisions with expert guidance from MAX@Home. We ensure a smooth, hassle-free experience from sample coordination to report delivery.
Book your Oncotype DX DCIS Test today to take the next step toward personalised cancer care.
Read More
The Role of Physiotherapy in Managing Cervical Pain
Cervical pain, commonly known as neck pain, is a widespread issue that affects many people at some p...
SGPT and SGOT Normal Range and Danger Levels: Symptoms, Risks, and Testing
SGPT (Serum Glutamate Pyruvate Transaminase) and SGOT (Serum Glutamate Oxaloacetate Transaminase) ar...
Understanding Normal Serum Creatinine Levels by Age and Gender: High, Low & Healthy Ranges Explained
Our kidneys work tirelessly to filter out waste and toxins such as urea, salts, electrolytes, and cr...
What is ESR Test: Normal Range And Possible Reasons For High ESR Levels
The Erythrocyte Sedimentation Rate (ESR) is a simple blood test that helps detect inflammation in th...
TSH Normal Range: Understanding Thyroid Levels by Age, Gender, and Health Conditions
Thyroid disorders are becoming increasingly common around the world, yet many people with thyroid im...
Gurgaon
I opted for GDA services from Max@Home and even though I was initially sceptical...
Delhi
The services provided by Max@Home were truly a blessing. The spontaneous and eff...
New Delhi
My name is Pallavi Shrivastava, and I was suffering from severe kidney problems...
Noida
I cannot thank Max@Home enough for the kind gesture that they have shown; I trie...
Delhi
My name is Sunil Singh, and last year I suffered from a severe cerebrovascular a...
Delhi
My name is Nishi Kashyap, and I opted for nursing procedure at home from Max@Hom...
My name is Nishi Kashyap, and I opted for home care services for the nursing pro...
Gurgaon
Had some tests done from Max at home. It was a smooth experience and Akhlaq Ahma...
Delhi
I have been availing MAX@Home services regularly for myself and family. Experien...
New Delhi
Mr Akhlaq form MAX@Home team came to my house for blood collection. He was perfe...
Noida
I had an excellent experience with the home blood collection service from MAX@Ho...
Delhi
Had a great experience with Ankit Kumar Singh from MAX@Home during a home blood...
Call: 9240299624
